The hypothalamic-pituitary-adrenal axis in women with differentiated thyroid cancer

Endocr Res. 2010;35(3):137-43. doi: 10.3109/07435800.2010.496760.

Abstract

Introduction: We studied the function of hypothalamic-pituitary-adrenal (HPA) axis in females with differentiated thyroid cancer (DTC) and its sequelae on metabolism and cardiovascular risk.

Methods and results: Sixteen women were investigated with (1) morning, evening, and midnight cortisol and adrenocortophic hormone, (2) cortisol after overnight 1 mg dexamethasone suppression test, (3) cortisol after corticotropin releasing hormone test, (4) oral glucose tolerance test with glucose and insulin estimations, and (5) ultrasound for carotid intima media thickness. A matched control group underwent similar investigations. None of the parameters was significantly different between patients and controls.

Conclusion: Females with DTC have normal HPA-axis function and similar insulin sensitivity and cardiovascular risk compared to controls.

MeSH terms

  • Adenocarcinoma, Follicular
  • Adrenocorticotropic Hormone / blood
  • Adult
  • Blood Glucose / analysis
  • Carcinoma
  • Carcinoma, Papillary
  • Cardiovascular Diseases / complications
  • Circadian Rhythm
  • Corticotropin-Releasing Hormone
  • Dexamethasone
  • Female
  • Glucose Tolerance Test
  • Humans
  • Hydrocortisone / blood
  • Hypothalamo-Hypophyseal System / physiopathology*
  • Insulin / blood
  • Insulin Resistance
  • Lipids / blood
  • Middle Aged
  • Pituitary-Adrenal System / physiopathology*
  • Thyroid Cancer, Papillary
  • Thyroid Neoplasms / physiopathology*

Substances

  • Blood Glucose
  • Insulin
  • Lipids
  • Dexamethasone
  • Adrenocorticotropic Hormone
  • Corticotropin-Releasing Hormone
  • Hydrocortisone